Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001–2004 NHANES
Article first published online: 7 DEC 2011
© 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK
Volume 29, Issue 1, pages 50–55, January 2012
How to Cite
Soderstrom, L. H., Johnson, S. P., Diaz, V. A. and Mainous, A. G. (2012), Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001–2004 NHANES. Diabetic Medicine, 29: 50–55. doi: 10.1111/j.1464-5491.2011.03379.x
- Issue published online: 7 DEC 2011
- Article first published online: 7 DEC 2011
- Accepted manuscript online: 4 JUL 2011 12:39PM EST
- Accepted 30 June 2011
- diabetes mellitus;
- peripheral neuropathy;
- vitamin D
Diabet. Med. 29, 50–55 (2012)
Aims To evaluate the association between vitamin D insufficiency and peripheral neuropathy in a nationally representative sample of adults with diagnosed diabetes.
Methods Vitamin D concentrations, medical examination variables and questionnaire results from the 2001–2004 National Health and Nutrition Examination Survey were analysed for adults ≥ 40 years old with diagnosed diabetes (unweighted n = 591, weighted n = 8.82 million). Neuropathy was defined as self report of peripheral neuropathy symptoms of painful sensation, tingling, numbness or loss of feeling in hands or feet. Additionally, Semmes–Weinstein monofilament test results were used as an indicator of neuropathy. Insufficient vitamin D was characterized as < 30 ng/ml.
Results In the weighted population, 81% of adults with diabetes had vitamin D insufficiency. Vitamin D insufficiency was more common among Hispanics (92%) and non-Hispanic black people (98%) than among non-Hispanic white people (76%). Within the 3 months preceding the questionnaire, 50% reported experiencing pain or numbness (paresthesia) in their hands or feet; 37% reported pain or tingling in hands or feet; and 38% reported numbness or loss of feeling in hands or feet. Eight per cent had 4–6 insensate areas on their feet as determined by the Semmes–Weinstein monofilament test. Logistic regressions demonstrate vitamin D insufficiency is associated with the adjusted composite paresthesia measure (odds ratio 2.12; 95% CI 1.17–3.85) and the adjusted numbness measure (odds ratio 2.04; 95% CI 1.18–3.52).
Conclusions Vitamin D insufficiency is associated with self-reported peripheral neuropathy symptoms even after adjusting for demographic factors, obesity, co-morbidities, use of medications for neuropathy and diabetes duration and control.